110 related articles for article (PubMed ID: 3058457)
21. HPLC analysis of insulin degradation products from isolated hepatocytes. Effects of inhibitors suggest intracellular and extracellular pathways.
Hamel FG; Peavy DE; Ryan MP; Duckworth WC
Diabetes; 1987 Jun; 36(6):702-8. PubMed ID: 3552802
[TBL] [Abstract][Full Text] [Related]
22. Identification of some cleavage sites of insulin by insulin proteinase.
Davies JG; Muir AV; Offord RE
Biochem J; 1986 Dec; 240(2):609-12. PubMed ID: 3545189
[TBL] [Abstract][Full Text] [Related]
23. Sequential insulin degradation in cultured fetal hepatocytes in relation to chloroquine-dependent events.
Zachayus JL; Khan S; Plas C
Am J Physiol; 1996 Sep; 271(3 Pt 1):E417-25. PubMed ID: 8843733
[TBL] [Abstract][Full Text] [Related]
24. Degradation of insulin by insulin-degrading enzyme and biological characteristics of its fragments.
Yonezawa K; Yokono K; Yaso S; Hari J; Amano K; Kawase Y; Sakamoto T; Shii K; Imamura Y; Baba S
Endocrinology; 1986 May; 118(5):1989-96. PubMed ID: 3516656
[TBL] [Abstract][Full Text] [Related]
25. Effect of bacitracin on retroendocytosis and degradation of insulin in cultured kidney epithelial cell line.
Dahl DC; Tsao T; Duckworth WC; Frank BH; Rabkin R
Diabetes; 1990 Nov; 39(11):1339-46. PubMed ID: 2227108
[TBL] [Abstract][Full Text] [Related]
26. Isolation of insulin degradation products from endosomes derived from intact rat liver.
Hamel FG; Posner BI; Bergeron JJ; Frank BH; Duckworth WC
J Biol Chem; 1988 May; 263(14):6703-8. PubMed ID: 3283131
[TBL] [Abstract][Full Text] [Related]
27. Tyrosine A14[125I]monoiodoinsulin: Preparation, Biologic Properties, and long-term stability.
Linde S; Hansen B; Sonne O; Holst JJ; Gliemann J
Diabetes; 1981 Jan; 30(1):1-8. PubMed ID: 7014299
[TBL] [Abstract][Full Text] [Related]
28. Insulin degradation by hepatocytes in primary culture.
Duckworth WC; Runyan KR; Wright RK; Halban PA; Solomon SS
Endocrinology; 1981 Apr; 108(4):1142-7. PubMed ID: 7009145
[TBL] [Abstract][Full Text] [Related]
29. The identification of a major product of the degradation of insulin by 'insulin proteinase' (EC 3.4.22.11).
Muir A; Offord RE; Davies JG
Biochem J; 1986 Aug; 237(3):631-7. PubMed ID: 3541902
[TBL] [Abstract][Full Text] [Related]
30. Degradation of the four monoiodoinsulin isomers by the insulin protease of rat liver.
Brush JS; Sonne O; Gliemann J
Biochim Biophys Acta; 1983 Jun; 757(3):269-73. PubMed ID: 6342683
[TBL] [Abstract][Full Text] [Related]
31. Biological properties of an initial degradation product of insulin by insulin-degrading enzyme.
Yonezawa K; Yokono K; Shii K; Hari J; Yaso S; Sakamoto T; Kawase Y; Akiyama H; Taketomi S; Baba S
Endocrinology; 1989 Jan; 124(1):496-504. PubMed ID: 2642422
[TBL] [Abstract][Full Text] [Related]
32. The characterisation of insulin degradation products in endosomes.
Seabright PJ; Smith GD
Biochem Soc Trans; 1995 Feb; 23(1):1S. PubMed ID: 7758656
[No Abstract] [Full Text] [Related]
33. Mechanisms involved in degradation of human insulin by cytosolic fractions of human, monkey, and rat liver.
Wroblewski VJ; Masnyk M; Khambatta SS; Becker GW
Diabetes; 1992 Apr; 41(4):539-47. PubMed ID: 1607078
[TBL] [Abstract][Full Text] [Related]
34. A14-[125I]monoiodoinsulin purified by different high-performance liquid chromatographic procedures and by polyacrylamide gel electrophoresis: preparation, immunochemical properties and receptor binding affinity.
Benzi L; Pezzino V; Marchetti P; Gullo D; Cecchetti P; Masoni A; Vigneri R; Navalesi R
J Chromatogr; 1986 Jun; 378(2):337-47. PubMed ID: 3525587
[TBL] [Abstract][Full Text] [Related]
35. Cellular and endosomal insulin degradation.
Duckworth WC; Hamel FG
Adv Second Messenger Phosphoprotein Res; 1990; 24():521-8. PubMed ID: 2119655
[No Abstract] [Full Text] [Related]
36. A14-125I-monoiodoinsulin purified by high performance liquid chromatography (HPLC): cellular receptor binding properties and long-term stability.
Benzi L; Marchetti P; Cecchetti P; Pezzino V; Gullo D; Masoni A; Navalesi R
J Nucl Med Allied Sci; 1984; 28(4):277-81. PubMed ID: 6399077
[No Abstract] [Full Text] [Related]
37. Insulin degradation: mechanisms, products, and significance.
Duckworth WC
Endocr Rev; 1988 Aug; 9(3):319-45. PubMed ID: 3061785
[TBL] [Abstract][Full Text] [Related]
38. Monoiodoinsulin labelled in tyrosine residue 16 or 26 of the B-chain or 19 of the A-chain. II. Characterization of the kinetic binding constants and determination of the biological potency.
Sonne O; Linde S; Larsen TR; Gliemann J
Hoppe Seylers Z Physiol Chem; 1983 Feb; 364(2):101-10. PubMed ID: 6341199
[TBL] [Abstract][Full Text] [Related]
39. Formation of insulin fragments by insulin-degrading enzyme: the role of zinc(II) and cystine bridges.
Bellia F; Pietropaolo A; Grasso G
J Mass Spectrom; 2013 Feb; 48(2):135-40. PubMed ID: 23378084
[TBL] [Abstract][Full Text] [Related]
40. Retroendocytosis of insulin in a cultured kidney epithelial cell line.
Dahl DC; Tsao T; Duckworth WC; Mahoney MJ; Rabkin R
Am J Physiol; 1989 Aug; 257(2 Pt 1):C190-6. PubMed ID: 2669506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
